AKT1 and cancer: When excluding AKT1-mutated patients and considering only NF1 mutations with more deleterious effects (nonsense, frameshift, and splicing variants), the most frequent cancer types are non-small cell lung cancer (12%), glioma (10%), and melanoma (9%).